AXIOM INVESTORS LLC /DE - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.

Quarter-by-quarter ownership
AXIOM INVESTORS LLC /DE ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2019$767,000
-60.0%
10,439
-48.6%
0.02%
-60.4%
Q2 2019$1,917,000
+47.8%
20,327
+25.5%
0.05%
+32.5%
Q1 2019$1,297,000
+27.0%
16,197
-14.4%
0.04%
+11.1%
Q4 2018$1,021,000
-34.3%
18,932
-4.9%
0.04%
-18.2%
Q3 2018$1,553,000
+14.3%
19,901
-7.1%
0.04%
+7.3%
Q2 2018$1,359,00021,4160.04%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders